Company Filing History:
2 out of 71 
1 out of 832,843 Years Active: 2018-2022
Title: Servando Palencia: Innovator in Cancer Treatment
Introduction
Servando Palencia is a notable inventor based in San Francisco, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic agents. With a total of 3 patents, Palencia's work focuses on the use of fibroblast growth factor receptor (FGFR) inhibitors in combination with immune-stimulating agents.
Latest Patents
Palencia's latest patents include groundbreaking methods for cancer treatment. One of his notable patents involves the use of FGFR2 inhibitors alone or in combination with immune-stimulating agents. This patent outlines the applications of FGFR2 inhibitors, which may include FGFR2 antibodies or FGFR2 extracellular domain (ECD) polypeptides. Additionally, it discusses the use of PD-1/PD-L1 inhibitors, which can inhibit interactions between these proteins, enhancing the effectiveness of cancer therapies. Another significant patent focuses on methods of treating lung cancer, particularly cancers that involve FGFR1 gene amplification. This patent details the administration of FGFR1 ECD and/or FGFR1 ECD fusion molecules, potentially in combination with other therapeutic agents.
Career Highlights
Throughout his career, Palencia has worked with various companies, including Five Prime Therapeutics, Inc. His experience in the biotechnology sector has allowed him to develop innovative solutions for cancer treatment, contributing to advancements in medical science.
Collaborations
Palencia has collaborated with notable professionals in his field, including Thomas Harding and Li Long. These collaborations have further enriched his research and development efforts, leading to impactful innovations in cancer therapies.
Conclusion
Servando Palencia is a distinguished inventor whose work in cancer treatment has the potential to change lives. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.